Abstract:In May 2023, the U.S. Food and Drug Administration (FDA) released guidance for industry on "Adjustment for Covariates in Randomized Clinical Trials for Drugs and Biological Products". Covariate adjustment is a statistical analysis method for improving precision and power in clinical trials by adjusting for pre-specified, prognostic baseline variables. Though recommended by the FDA and the European Medicines Agency (EMA), many trials do not exploit the available information in baseline variables or make use only of the baseline measurement of the outcome. This is likely (partly) due to the regulatory mandate to pre-specify baseline covariates for adjustment, leading to challenges in determining appropriate covariates and their functional forms. We will explore the potential of automated data-adaptive methods, such as machine learning algorithms, for covariate adjustment, addressing the challenge of pre-specification. Specifically, our approach allows the use of complex models or machine learning algorithms without compromising the interpretation or validity of the treatment effect estimate and its corresponding standard error, even in the presence of misspecified outcome working models. This contrasts the majority of competing works which assume correct model specification for the validity of standard errors. Our proposed estimators either necessitate ultra-sparsity in the outcome model (which can be relaxed by limiting the number of predictors in the model) or necessitate integration with sample splitting to enhance their performance. As such, we will arrive at simple estimators and standard errors for the marginal treatment effect in randomized clinical trials, which exploit data-adaptive outcome predictions based on prognostic baseline covariates, and have low (or no) bias in finite samples even when those predictions are themselves biased.

Incorporating External Data for Analyzing Randomized Clinical Trials: A Transfer Learning Approach

Incorporating External Data into the Analysis of Clinical Trials via Bayesian Additive Regression Trees

Regression-based multiple treatment effect estimation under covariate-adaptive randomization

A matching design for augmenting a randomized clinical trial with external control

Regression Analysis for Covariate-Adaptive Randomization: A Robust and Efficient Inference Perspective

A propensity score‐integrated approach for leveraging external data in a randomized controlled trial with time‐to‐event endpoints

Integrating Randomized Placebo-Controlled Trial Data with External Controls: A Semiparametric Approach with Selective Borrowing

Lasso-adjusted treatment effect estimation under covariate-adaptive randomization

A Unified Framework for Covariate Adjustment under Stratified Randomization

Automated, efficient and model-free inference for randomized clinical trials via data-driven covariate adjustment

Matching within a hybrid RCT/RWD: framework on associated causal estimands

Leveraging historical data to optimize the number of covariates and their explained variance in the analysis of randomized clinical trials.

Robust integration of external control data in randomized trials

A Practical Analysis Procedure on Generalizing Comparative Effectiveness in the Randomized Clinical Trial to the Real-world Trialeligible Population

Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information

A general theory of regression adjustment for covariate-adaptive randomization: OLS, Lasso, and beyond

Improving transportability of randomized controlled trial inference using robust prediction methods

A Unified Framework for Covariate Adjustment Under Stratified Randomisation

Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups

Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials

Adaptively leverage multiple real-world data sources for treatment effect estimation based on similarity